Hemoglobin Oxygen Therapeutics
Souderton, US · Founded 2014 · Delaware LLC
Founders & leadership
IB
Igor Borisovich SerovChief Financial Officer
GR
Gerald Raymond KowalskiManager and Chief Executive Officer
ZG
Zafiris George ZafirelisManager and President
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 2 rounds · 2014–2015
▶$150KraisedApr 2015 · 2 investors · BiotechnologyRule 506(b)
▶$150KraisedApr 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Igor Borisovich SerovExecutive Officer
- Zafiris George ZafirelisExecutive Officer, Director
- Gerald Raymond KowalskiExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $150K
- Minimum investment
- $50K
- First sale
- Apr 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$1.3MraisedMar 2015 · 3 investors · BiotechnologyRule 506(b)
▶$1.3MraisedMar 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Igor Borisovich SerovExecutive Officer
- Gerald Raymond KowalskiExecutive Officer, Director
- Zafiris George ZafirelisExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- First sale
- Jul 2014
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Hemoglobin Oxygen Therapeutics raised?
- Hemoglobin Oxygen Therapeutics has disclosed $1.5M raised across 2 rounds.
- Where is Hemoglobin Oxygen Therapeutics headquartered?
- Hemoglobin Oxygen Therapeutics is headquartered in Souderton, US.